Geneva Capital Management LLC Charles River Laboratories International, Inc. Transaction History
Geneva Capital Management LLC
- $5.68 Billion
- Q4 2024
A detailed history of Geneva Capital Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Geneva Capital Management LLC holds 12,790 shares of CRL stock, worth $1.99 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
12,790
Previous 14,816
13.67%
Holding current value
$1.99 Million
Previous $2.92 Million
19.09%
% of portfolio
0.04%
Previous 0.05%
Shares
12 transactions
Others Institutions Holding CRL
# of Institutions
709Shares Held
49.8MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$958 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$791 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$339 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$281 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$281 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.91B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...